TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has provided an announcement.
Piramal Pharma Limited announced the approval of a resolution to appoint Ms. Nathalie Leitch as a Non-Executive, Non-Independent Director following a postal ballot and remote e-voting process. The resolution was passed with the requisite majority, reflecting shareholder support and potentially strengthening the company’s governance structure.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company provides a range of services and products, including critical care, consumer products, and contract development and manufacturing services, catering to a global market.
YTD Price Performance: -15.36%
Average Trading Volume: 382,791
Current Market Cap: 282.1B INR
For a thorough assessment of PPLPHARMA stock, go to TipRanks’ Stock Analysis page.